ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,683.00
-0.01%
S&P ASX All Technology
3,008.10
0.02%
Brent Oil
87.315
0.11%
US Dollar vs AUD
1.53135
-0.51%
Bitcoin
63,813.71
-0.73%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Karuna Therapeutics Inc (KRTX)

  7. Karuna Therapeutics Inc (KRTX) News

KRTX Karuna Therapeutics Inc

329.83
0.00 (0.00%)
Pre Market
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Karuna Therapeutics Inc KRTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 329.83 10:00:00
Open Price Low Price High Price Close Price Previous Close
329.83
more quote information »

Recent News

Date Time Source Heading
12/3/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:01EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/3/202422:01EDGAR2Form 8-K - Current report
22/2/202422:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202422:32EDGAR2Form 8-K - Current report
22/2/202422:30BWKaruna Therapeutics Reports Fourth Quarter and Full Year..
16/2/202408:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202408:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202408:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202408:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202409:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202409:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202403:56EDGAR2Form 144 - Report of proposed sale of securities
06/2/202408:12EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
22/1/202422:05EDGAR2Form PREM14A - Preliminary proxy statements relating to..
17/1/202408:18EDGAR2Form 8-K - Current report
10/1/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:18EDGAR2Form 144 - Report of proposed sale of securities
09/1/202402:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
30/12/202308:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202309:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202309:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202309:07EDGAR2Form 8-K - Current report
23/12/202308:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202308:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202308:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202307:30PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
23/12/202303:15DJNTrending: Bristol Myers to Buy Karuna Therapeutics for $14..
23/12/202300:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202300:26EDGAR2Form 8-K - Current report
22/12/202323:05BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
22/12/202322:59BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
15/12/202310:30BWKaruna Therapeutics Announces The Lancet Publication of Data..
13/12/202308:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202307:24EDGAR2Form 144 - Report of proposed sale of securities
30/11/202302:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
29/11/202323:13DJNKaruna Therapeutics Gets FDA Acceptance for KarXT NDA
29/11/202322:30BWKaruna Therapeutics Announces U.S. Food and Drug..
17/11/202308:01BWKaruna Therapeutics Announces Positive Results from Phase 1b..
14/11/202309:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202308:25EDGAR2Form 144 - Report of proposed sale of securities
02/11/202321:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:36EDGAR2Form 8-K - Current report
02/11/202321:30BWKaruna Therapeutics Reports Third Quarter 2023 Financial..
01/11/202321:45BWKaruna Therapeutics to Present Data from the EMERGENT..
01/11/202321:30BWKaruna Therapeutics to Present at Upcoming Investor..
19/10/202321:30BWKaruna Therapeutics to Announce Third Quarter 2023 Financial..
11/10/202307:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
KRTX
Karuna Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved